| Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma (NCT05041127) | M.D. Anderson Cancer Center | 2022-05-27 |
| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone (NCT05033288) | Mayo Clinic | 2022-01-20 |
| Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas (NCT04832620) | Leiden University Medical Center | 2021-02-02 |
| TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer (NCT04246671) | Bavarian Nordic | 2020-08-10 |
| Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis Care (NCT04486820) | Centre Hospitalier Universitaire de Saint Etienne | 2020-04-01 |
| Pemetrexed for the Treatment of Chordoma (NCT03955042) | Saint John's Cancer Institute | 2019-09-06 |
| Long-Term Longitudinal QoL in Patients Undergoing EEA (NCT04087902) | Ohio State University | 2019-07-16 |
| Children and Adults With Chordoma (NCT03910465) | National Cancer Institute (NCI) | 2019-04-16 |
| Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma (NCT03623854) | Jonsson Comprehensive Cancer Center | 2019-04-03 |
| BN Brachyury and Radiation in Chordoma (NCT03595228) | Bavarian Nordic | 2018-10-31 |
| QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. (NCT03647423) | ImmunityBio, Inc. | 2018-08-31 |
| Afatinib in Locally Advanced and Metastatic Chordoma (NCT03083678) | Leiden University Medical Center | 2018-06-21 |
| CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT03110744) | University Hospital Heidelberg | 2017-12-15 |
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers (NCT03190174) | Sarcoma Oncology Research Center, LLC | 2017-08-24 |
| Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (NCT03242382) | Grupo Espanol de Investigacion en Sarcomas | 2017-03-31 |
| Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease (NCT02986516) | Italian Sarcoma Group | 2017-03-16 |
| Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma (NCT02989636) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-10 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas (NCT01567046) | Children's Oncology Group | 2016-05-01 |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma (NCT02520128) | University College, London | 2016-03-01 |
| QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma (NCT02383498) | NantCell, Inc. | 2015-05-01 |
| Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma (NCT01175109) | Deric M Park MD | 2011-10-01 |
| Nilotinib With Radiation for High Risk Chordoma (NCT01407198) | Massachusetts General Hospital | 2011-08-01 |
| Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base (NCT01182779) | Heidelberg University | 2010-07-01 |
| Stereotactic Body Radiotherapy for Spine Tumors (NCT01347307) | Mercy Research | 2008-09-01 |
| Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas (NCT00713037) | Massachusetts General Hospital | 2008-06-01 |
| Trial of Dasatinib in Advanced Sarcomas (NCT00464620) | Sarcoma Alliance for Research through Collaboration | 2007-05-01 |
| Proton Beam Therapy for Chordoma Patients (NCT00496119) | M.D. Anderson Cancer Center | 2006-09-18 |
| Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer (NCT00349024) | Children's Cancer and Leukaemia Group | 2005-07-01 |
| Efficacy and Safety of Imatinib in Chordoma (NCT00150072) | Novartis Pharmaceuticals | 2004-10-01 |
| Chordoma Family Study (NCT00410670) | National Cancer Institute (NCI) | 2003-08-01 |
| Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine (NCT00592748) | Massachusetts General Hospital | 1999-06-01 |
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma (NCT00919269) | Children's Oncology Group | 1999-03-15 |
| Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families (NCT00341627) | National Cancer Institute (NCI) | 1999-02-01 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast (NCT04091295) | Aveni Foundation | |